Orbimed Capital Gp Vii Llc - Net Worth and Insider Trading
Orbimed Capital Gp Vii Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Orbimed Capital Gp Vii Llc owns 16 companies in total, including Arcutis Biotherapeutics Inc (ARQT) , Pandion Therapeutics Inc (PAND) , and Fusion Pharmaceuticals Inc (FUSN) among others .
Click here to see the complete history of Orbimed Capital Gp Vii Llc’s form 4 insider trades.
Insider Ownership Summary of Orbimed Capital Gp Vii Llc
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ARQT | Arcutis Biotherapeutics Inc | 2020-02-03 | director & 10 percent owner |
PAND | Pandion Therapeutics Inc | 2020-07-16 | 10 percent owner |
FUSN | Fusion Pharmaceuticals Inc | 2020-06-25 | director |
RPTX | Repare Therapeutics Inc | 2021-08-17 | director |
KROS | Keros Therapeutics Inc | 2020-04-07 | director |
IMRA | Imara Inc | 2020-03-11 | director & 10 percent owner |
PASG | Passage Bio Inc | 2022-01-11 | 10 percent owner |
SRRA | Sierra Oncology Inc | 2019-11-22 | director & 10 percent owner |
THOR | Synthorx Inc | 2018-12-11 | 10 percent owner |
THRX | Theseus Pharmaceuticals Inc | 2021-10-06 | 10 percent owner |
KNTE | Kinnate Biopharma Inc | 2022-02-11 | director |
GLTO | Galecto Inc | 2020-10-28 | director & 10 percent owner |
JANX | Janux Therapeutics Inc | 2021-12-16 | director |
TERN | Terns Pharmaceuticals Inc | 2022-08-16 | director & 10 percent owner |
THRD | Third Harmonic Bio Inc | 2022-09-14 | director & 10 percent owner |
ELVN | Enliven Therapeutics Inc | 2020-03-11 | director & 10 percent owner |
Orbimed Capital Gp Vii Llc Trading Performance
Orbimed Capital Gp Vii Llc Ownership Network
Ownership Network List of Orbimed Capital Gp Vii Llc
Ownership Network Relation of Orbimed Capital Gp Vii Llc
Orbimed Capital Gp Vii Llc Owned Company Details
What does Arcutis Biotherapeutics Inc do?
Who are the key executives at Arcutis Biotherapeutics Inc?
Orbimed Capital Gp Vii Llc is the director & 10 percent owner of Arcutis Biotherapeutics Inc. Other key executives at Arcutis Biotherapeutics Inc include SVP and Chief Business Officer Matthew Richard Moore , director & 10 percent owner Patrick J Heron , and director & President and CEO Todd Franklin Watanabe .
Arcutis Biotherapeutics Inc (ARQT) Insider Trades Summary
Over the past 18 months, Orbimed Capital Gp Vii Llc made no insider transaction in Arcutis Biotherapeutics Inc (ARQT). Other recent insider transactions involving Arcutis Biotherapeutics Inc (ARQT) include a net sale of 30,155 shares made by Todd Franklin Watanabe , a net sale of 37,403 shares made by Howard G. Welgus , and a net sale of 10,594 shares made by Masaru Matsuda .
In summary, during the past 3 months, insiders sold 29,378 shares of Arcutis Biotherapeutics Inc (ARQT) in total and bought 21,052 shares, with a net sale of 8,326 shares. During the past 18 months, 104,916 shares of Arcutis Biotherapeutics Inc (ARQT) were sold and 102,515 shares were bought by its insiders, resulting in a net sale of 2,401 shares.
Arcutis Biotherapeutics Inc (ARQT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arcutis Biotherapeutics Inc Insider Transactions
Orbimed Capital Gp Vii Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Orbimed Capital Gp Vii Llc. You might contact Orbimed Capital Gp Vii Llc via mailing address: 601 Lexington Avenue, 54th Floor, New York Ny 10022.